Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07081139

Visual Function Screening System With Special Needs Children and Typical Preschoolers

The early visual screening of children plays a critical role in promoting visual development, especially for those with visual impairments. Among various approaches, eye-tracking based visual assessment has emerged as a promising tool, particularly for infants, toddlers, and children with developmental disabilities who are unable to complete traditional vision tests. The object of this study is to design and investigate the effectiveness of using a deep learning based, individualized eye-tracking system to assess visual function, specifically visual acuity and visual field, in typical preschool children and infants under the age of three. This study aims to establish a reliable, noninvasive visual screening method that accommodates the diverse needs and abilities of young children.

Recruiting

Interested in participating?

Request Info

Key information

Age range

0 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Ophthalmology, National Taiwan University Hospital

Taipei, Taiwan

Location status: Recruiting

Location contact

Chiun-Ho Hou, PHD

CONTACT

[email protected]

+886-972652487

About this study

The investigators will recruit a total of 1,300 participants across four key groups to support the development and validation of an individualized visual function screening system using eye-tracking technology:

  • 300 adults to establish a reference dataset for gaze estimation models
  • 300 typically developing preschool children aged 3 to 5 years
  • 400 typically developing children under the age of 3
  • 300 children with special needs, including those with developmental disabilities and visual impairments Data collection will take place over 15 to 22 months, depending on the group.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • A. General Group 1. Inclusion Criteria

General adults:

  • Aged over 18 and under 70 years
  • Willing to undergo assessment and video recording using the "Deep Visual Tracking System"
  • Willing to sign the informed consent form

Typically developing preschool children aged 3 to 5:

  • Currently aged between 3 (inclusive) and 5 (inclusive) years
  • The primary caregiver agrees to allow the child to undergo assessment and video recording using the "Deep Visual Tracking System"

Children under 3 years old:

  • Currently under 3 years of age
  • The primary caregiver agrees to allow the child to undergo assessment and video recording using the "Deep Visual Tracking System"
  • Exclusion Criteria

General adults:

  • Presence of severe corneal disease or cataract that may interfere with data collection
  • Obvious abnormalities in eye or facial appearance, such as ptosis or facial trauma affecting facial structure

Typically developing preschool children aged 3 to 5:

  • Children with physical or mental disabilities
  • Children diagnosed with or suspected of having developmental delay
  • Children with obvious abnormalities in eye or facial appearance

Children under 3 years old:

(1) Children with physical or mental disabilities (2) Children diagnosed with or suspected of having developmental delay (3) Children with obvious abnormalities in eye or facial appearance

________________________________________ B. Special Needs Group

  • Inclusion Criteria (1) Children under the age of 12 with special needs, including physical, mental, or multiple disabilities (2) The primary caregiver agrees to allow the child to undergo assessment and video recording using the "Deep Visual Tracking System"
  • Exclusion Criteria (1) Children with refractive errors that are diagnosed by an ophthalmologist to significantly impair vision and are unable to wear corrective glasses during assessment (2) Children who are physiologically or emotionally unstable and unable to adapt and complete at least two assessment sessions

B. Special Needs Group

  • Inclusion Criteria (1) Children under the age of 12 with special needs, including physical, mental, or multiple disabilities (2) The primary caregiver agrees to allow the child to undergo assessment and video recording using the "Deep Visual Tracking System"

Exclusion criteria

  • A. General Group
  • Exclusion Criteria

General adults:

  • Presence of severe corneal disease or cataract that may interfere with data collection
  • Obvious abnormalities in eye or facial appearance, such as ptosis or facial trauma affecting facial structure

Typically developing preschool children aged 3 to 5:

  • Children with physical or mental disabilities
  • Children diagnosed with or suspected of having developmental delay
  • Children with obvious abnormalities in eye or facial appearance

Children under 3 years old:

  • Children with physical or mental disabilities
  • Children diagnosed with or suspected of having developmental delay
  • Children with obvious abnormalities in eye or facial appearance

B. Special Needs Group 2. Exclusion Criteria

  • Children with refractive errors that are diagnosed by an ophthalmologist to significantly impair vision and are unable to wear corrective glasses during assessment
  • Children who are physiologically or emotionally unstable and unable to adapt and complete at least two assessment sessions

Treatment and study plan

observational study, no interventional

Other

no interventions

Primary outcomes

  1. Accuracy of Visual Acuity Classification by Deep Vision Tracking System (DVR System), Compared to Standard Clinical Assessment

    Time frame: 2 months

    Compare the DVR system's classification (normal vs. impaired vision) with results from standard clinical tests (e.g., Teller Acuity Cards). Report sensitivity and specificity. Cut-off values: logMAR 0.22 (Snellen decimal: 0.6) and 0.097 (Snellen decimal: 0.8).

  2. Visual Field Detection Accuracy of the DVR System Compared to Standard Evaluation

    Time frame: 2 months

    This outcome assesses the accuracy of the DVR system in detecting visual field response in children, defined by whether the participant successfully fixates on screen-displayed peripheral stimuli. The DVR system's outputs will be compared to clinical observation. Accuracy will be evaluated via sensitivity and specificity.

Secondary outcomes

  1. Criterion validity of DVR system visual acuity estimates (logMAR)

    Time frame: 2 months

    Compare DVR system logMAR estimates with clinical measurements (e.g., Teller Acuity Cards) using linear regression. Report slope coefficient; a slope near 1 indicates strong agreement. Target criterion: slope ≥ 0.8.

  2. Test-retest reliability of DVR system visual acuity measurements

    Time frame: 2 months

    Participants will be re-tested within 2 weeks. Reliability will be assessed using standard error of measurement and coefficient of variation from panel data.

Study contacts

Contact information is provided by the study sponsor or research team.

Chiun-Ho Hou, PHD

CONTACT

[email protected]

+886-972652487

Sponsors and collaborators

Lead sponsor

National Taiwan University Hospital

Other

Registry information

Official study title

Leveraging Deep Learning to Optimize the Individualized Application of Eye-tracking Devices for the Early-stage Visual Function Screening of Both Special Needs Children and Typical Preschoolers

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Jul 23, 2025
Registry last updated
Nov 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.